2-Aminothiazole derivatives as antimycobacterial agents: Synthesis, characterization, in vitro and in silico studies

被引：45

作者：

Makam, Parameshwar ^{[1
]}

Kannan, Tharanikkarasu ^{[1
]}

机构：

[1] Pondicherry Univ, Dept Chem, Pondicherry 605014, India

来源：

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2014年 / 87卷

关键词：

Mycobacterium tuberculosis; Tuberculosis; 2-Aminothiazole; Drug like molecule; beta-Ketoacyl-ACP Synthase; Docking studies; MYCOBACTERIUM-TUBERCULOSIS; CRYSTAL-STRUCTURES; DRUG DISCOVERY; DESIGN; INHIBITORS; MOLECULE;

D O I：

10.1016/j.ejmech.2014.09.086

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of 2-aminothiazole derivatives with a wide range of substitutions at 2-, 4- and 5-positions were designed and synthesized using Hantzsch thiazole synthesis. These compounds were evaluated for their inhibitory potential against Mycobacterium tuberculosis (Mtb), H(37)Rv. The compound. 7n showed high antimycobacterial activity with WC value of 6.25 mu M and the succeeding compounds, 7b, 7e and 7f also exhibited antimycobacterial activity with MIC value of 12.50 mu M. Docking studies of these molecules with beta-Ketoacyl-ACP Synthase (KasA) protein of Mtb have been carried out to understand the mechanism of antimycobacterial action. The compound, 7n showed good interaction with KasA protein with the K-i value of 0.44 mu M. (c) 2014 Elsevier Masson SAS. All rights reserved.

引用

页码：643 / 656

页数：14

共 63 条

[31]

Khojasteh SC, 2011, DRUG METABOLISM AND PHARMACOKINETICS QUICK GUIDE, P165, DOI 10.1007/978-1-4419-5629-3_9

[32] Whole-Genome Sequencing for Rapid Susceptibility Testing of M-tuberculosis [J].

Koeser, Claudio U. ;

Bryant, Josephine M. ;

Becq, Jennifer ;

Toeroek, M. Estee ;

Ellington, Matthew J. ;

Marti-Renom, Marc A. ;

Carmichael, Andrew J. ;

Parkhill, Julian ;

Smith, Geoffrey P. ;

Peacock, Sharon J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (03) :290-292

[33] Adamantane derivatives of thiazolyl-N-substituted amide, as possible non-steroidal anti-inflammatory agents [J].

Kouatly, Omar ;

Geronikaki, Athina ;

Kamoutsis, Charalambos ;

Hadjipavlou-Litina, Dimitra ;

Eleftheriou, Phaedra .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (03) :1198-1204

[34] The challenge of new drug discovery for tuberculosis [J].

Koul, Anil ;

Arnoult, Eric ;

Lounis, Nacer ;

Guillemont, Jerome ;

Andries, Koen .

NATURE, 2011, 469 (7331) :483-490

[35] HIV and Tuberculosis: a Deadly Human Syndemic [J].

Kwan, Candice K. ;

Ernst, Joel D. .

CLINICAL MICROBIOLOGY REVIEWS, 2011, 24 (02) :351-+

[36] The influence of drug-like concepts on decision-making in medicinal chemistry [J].

Leeson, Paul D. ;

Springthorpe, Brian .

NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (11) :881-890

[37] Efficacy and Safety of a 4-Drug Fixed-Dose Combination Regimen Compared With Separate Drugs for Treatment of Pulmonary Tuberculosis The Study C Randomized Controlled Trial [J].

Lienhardt, Christian ;

Cook, Sharlette V. ;

Burgos, Marcos ;

Yorke-Edwards, Victoria ;

Rigouts, Leen ;

Anyo, Gladys ;

Kim, Sang-Jae ;

Jindani, Amina ;

Enarson, Don A. ;

Nunn, Andrew J. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (14) :1415-1423

[38] Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings (Reprinted from Advanced Drug Delivery Reviews, vol 23, pg 3-25, 1997) [J].

Lipinski, CA ;

Lombardo, F ;

Dominy, BW ;

Feeney, PJ .

ADVANCED DRUG DELIVERY REVIEWS, 2001, 46 (1-3) :3-26

[39] Crystal Structures of Mycobacterium tuberculosis KasA Show Mode of Action within Cell Wall Biosynthesis and its Inhibition by Thiolactomycin [J].

Luckner, Sylvia R. ;

Machutta, Carl A. ;

Tonge, Peter J. ;

Kisker, Caroline .

STRUCTURE, 2009, 17 (07) :1004-1013

[40] In vitro and in silico antimalarial activity of 2-(2-hydrazinyl)thiazole derivatives [J].

Makam, Parameshwar ;

Thakur, Prasoon Kumar ;

Kannan, Tharanikkarasu .

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 52 :138-145

← 1 2 3 4 5 6 7 →